Additionally, SE-lncRNAs such as TMEM44-AS1, CCAT1, LINC00152, and NEAT1 are identified as facilitators of glioma malignancy, reinforcing the prognostic and therapeutic potential of SE-lncRNA signatures [114]. Here, TMEM44 is linked to glioma.